Stocks
Parabilis Medicines, Inc.PBLS
NASDAQHealthcareBiotechnology$28.02
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing mRNA-based therapies for rare diseases. Its lead programs target genetic disorders with high unmet medical need, and investors track it for its platform potential and upcoming clinical data readouts.
52W Range: $22.66-$42.49
Congressional Interest in Parabilis Medicines, Inc. (PBLS)
No congressional trades have been disclosed for Parabilis Medicines, Inc. (PBLS) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PBLS?
No congressional trades found for this stock.